organization · Reporting owner
IVP Executive Fund XVI, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hims & Hers Health, Inc.
Report date March 02, 2023 · Filed March 06, 2023
Jointly reported with INSTITUTIONAL VENTURE MANAGEMENT XV, LLC, INSTITUTIONAL VENTURE MANAGEMENT XVI, LLC, Institutional Venture Partners XV, L.P., Institutional Venture Partners XV Executive Fund, L.P., Institutional Venture Partners XVI, L.P.
Section 16 reporting ended · disclosed 2023-03-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy Institutional Venture Partners XV, L.P. | 7,668,334 |
Reported balance
After 2023-03-02 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-03-02 · Other · Disposed 2,486,770 · Balance 7,668,334 F1: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XV, L.P. ("IVP XV") to its general partner and limited partners without additional consideration. F2: The shares held by Institutional Venture Management XV, LLC ("IVM XV") prior to the transactions reported herein reflect the transfer of shares from IVM XV to IVP XV, which shares were previously held by IVM XV for the benefit of IVP XV and such transfer did not constitute a change in beneficial ownership. F3: Shares are held by IVP XV. IVM XV is the sole general partner of IVP XV. Todd C. Chaffee, Somesh Dash, Norman A. Fogelsong, Stephen J. Harrick, Eric Liaw, J. Sanford Miller, Dennis B. Phelps and Jules A. Maltz (collectively, the "Managing Directors") are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV. Each of IVM XV and the Managing Directors disclaims beneficial ownership of the shares held by IVP XV except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Institutional Venture Partners XV Executive Fund, L.P. | 40,786 |
Reported balance
After 2023-03-02 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2023-03-02 · Other · Disposed 13,188 · Balance 40,786 F4: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV EF") to its limited partners without additional consideration. F5: Shares are held by IVP XV EF. IVM XV is the sole general partner of IVP XV EF. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV EF. Each of IVM XV and the Managing Directors disclaims beneficial ownership of these securities, except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Institutional Venture Partners XVI, L.P. | 7,709,091 |
Reported balance
After 2023-03-02 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2023-03-02 · Other · Disposed 2,500,000 · Balance 7,709,091 F6: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XVI, L.P. ("IVP XVI") to its general partner and limited partners without additional consideration. F7: The shares held by Institutional Venture Management XVI, LLC ("IVM XVI") prior to the transactions reported herein reflect the transfer of shares from IVM XVI to IVP XVI, which shares were previously held by IVM XVI for the benefit of IVP XVI and such transfer did not constitute a change in beneficial ownership. F8: Shares are held by IVP XVI. IVM XVI is the sole general partner of IVP XVI. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XVI. Each of IVM XVI and the Managing Directors disclaims beneficial ownership of these securities, except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. |
| Class A Common StockSEC Table I · non-derivative | Direct | 537,143 |
Reported balance
After 2023-03-02 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2023-03-02 · Other · Acquired 537,143 · Balance 537,143 F9: Represents receipt of shares in the distribution in kind described in footnote (1). F2: The shares held by Institutional Venture Management XV, LLC ("IVM XV") prior to the transactions reported herein reflect the transfer of shares from IVM XV to IVP XV, which shares were previously held by IVM XV for the benefit of IVP XV and such transfer did not constitute a change in beneficial ownership. F10: Shares are held by IVM XV. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVM XV. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XV except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. |
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-03-02 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2023-03-02 · Other · Disposed 537,143 · Balance 0 F11: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by IVM XV to its members without additional consideration. F10: Shares are held by IVM XV. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVM XV. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XV except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy IVP Executive Fund XVI, LLC | 33,180 |
Reported balance
After 2023-03-02 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2023-03-02 · Other · Acquired 33,180 · Balance 33,180 F12: Represents receipt of shares in the distribution in kind described in footnote (6). F13: Shares are held by IVP Executive Fund XVI, LLC ("IVP XVI EF"). IVM XVI is the manager of IVP XVI EF. The Managing Directors are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVP XVI EF. IVM XVI and each of the Managing Directors disclaims beneficial ownership of the shares held by IVP XVI EF except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Institutional Venture Management XVI, LLC | 62,500 |
Reported balance
After 2023-03-02 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2023-03-02 · Other · Acquired 62,500 · Balance 62,500 F12: Represents receipt of shares in the distribution in kind described in footnote (6). F7: The shares held by Institutional Venture Management XVI, LLC ("IVM XVI") prior to the transactions reported herein reflect the transfer of shares from IVM XVI to IVP XVI, which shares were previously held by IVM XVI for the benefit of IVP XVI and such transfer did not constitute a change in beneficial ownership. F14: Shares are held by IVM XVI. The Managing Directors are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVM XVI. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XVI except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Institutional Venture Management XVI, LLC | 0 |
Reported balance
After 2023-03-02 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2023-03-02 · Other · Disposed 62,500 · Balance 0 F15: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by IVM XVI to its members without additional consideration. F14: Shares are held by IVM XVI. The Managing Directors are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVM XVI. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XVI except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XV, L.P. ("IVP XV") to its general partner and limited partners without additional consideration.
F2: The shares held by Institutional Venture Management XV, LLC ("IVM XV") prior to the transactions reported herein reflect the transfer of shares from IVM XV to IVP XV, which shares were previously held by IVM XV for the benefit of IVP XV and such transfer did not constitute a change in beneficial ownership.
F3: Shares are held by IVP XV. IVM XV is the sole general partner of IVP XV. Todd C. Chaffee, Somesh Dash, Norman A. Fogelsong, Stephen J. Harrick, Eric Liaw, J. Sanford Miller, Dennis B. Phelps and Jules A. Maltz (collectively, the "Managing Directors") are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV. Each of IVM XV and the Managing Directors disclaims beneficial ownership of the shares held by IVP XV except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
F4: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV EF") to its limited partners without additional consideration.
F5: Shares are held by IVP XV EF. IVM XV is the sole general partner of IVP XV EF. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV EF. Each of IVM XV and the Managing Directors disclaims beneficial ownership of these securities, except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
F6: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XVI, L.P. ("IVP XVI") to its general partner and limited partners without additional consideration.
F7: The shares held by Institutional Venture Management XVI, LLC ("IVM XVI") prior to the transactions reported herein reflect the transfer of shares from IVM XVI to IVP XVI, which shares were previously held by IVM XVI for the benefit of IVP XVI and such transfer did not constitute a change in beneficial ownership.
F8: Shares are held by IVP XVI. IVM XVI is the sole general partner of IVP XVI. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XVI. Each of IVM XVI and the Managing Directors disclaims beneficial ownership of these securities, except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
F9: Represents receipt of shares in the distribution in kind described in footnote (1).
F10: Shares are held by IVM XV. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVM XV. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XV except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
F11: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by IVM XV to its members without additional consideration.
F12: Represents receipt of shares in the distribution in kind described in footnote (6).
F13: Shares are held by IVP Executive Fund XVI, LLC ("IVP XVI EF"). IVM XVI is the manager of IVP XVI EF. The Managing Directors are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVP XVI EF. IVM XVI and each of the Managing Directors disclaims beneficial ownership of the shares held by IVP XVI EF except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
F14: Shares are held by IVM XVI. The Managing Directors are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVM XVI. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XVI except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports.
F15: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by IVM XVI to its members without additional consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2023 Filed Mar 6, 2023 21:43 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016320 · doc4.xml · nonDerivative · entry 8 Institutional Venture Management XV, LLC · CIK 0001640275 · 10% owner Institutional Venture Management XVI, LLC · CIK 0001716997 · 10% owner Institutional Venture Partners XV, L.P. · CIK 0001640274 · 10% owner Institutional Venture Partners XV Executive Fund, L.P. · CIK 0001661321 · 10% owner Institutional Venture Partners XVI, L.P. · CIK 0001716992 · 10% owner IVP Executive Fund XVI, LLC · CIK 0001716965 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Institutional Venture Management XVI, LLC Disclosed balance after: 0 F15 · kind: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by IVM XVI to its members without additional consideration. F14 · ownership.nature: Shares are held by IVM XVI. The Managing Directors are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVM XVI. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XVI except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:43 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016320 · doc4.xml · nonDerivative · entry 7 Institutional Venture Management XV, LLC · CIK 0001640275 · 10% owner Institutional Venture Management XVI, LLC · CIK 0001716997 · 10% owner Institutional Venture Partners XV, L.P. · CIK 0001640274 · 10% owner Institutional Venture Partners XV Executive Fund, L.P. · CIK 0001661321 · 10% owner Institutional Venture Partners XVI, L.P. · CIK 0001716992 · 10% owner IVP Executive Fund XVI, LLC · CIK 0001716965 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Institutional Venture Management XVI, LLC Disclosed balance after: 62,500 F12 · kind: Represents receipt of shares in the distribution in kind described in footnote (6). F7 · balance_after: The shares held by Institutional Venture Management XVI, LLC ("IVM XVI") prior to the transactions reported herein reflect the transfer of shares from IVM XVI to IVP XVI, which shares were previously held by IVM XVI for the benefit of IVP XVI and such transfer did not constitute a change in beneficial ownership. F14 · ownership.nature: Shares are held by IVM XVI. The Managing Directors are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVM XVI. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XVI except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:43 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 33,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016320 · doc4.xml · nonDerivative · entry 6 Institutional Venture Management XV, LLC · CIK 0001640275 · 10% owner Institutional Venture Management XVI, LLC · CIK 0001716997 · 10% owner Institutional Venture Partners XV, L.P. · CIK 0001640274 · 10% owner Institutional Venture Partners XV Executive Fund, L.P. · CIK 0001661321 · 10% owner Institutional Venture Partners XVI, L.P. · CIK 0001716992 · 10% owner IVP Executive Fund XVI, LLC · CIK 0001716965 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By IVP Executive Fund XVI, LLC Disclosed balance after: 33,180 F12 · kind: Represents receipt of shares in the distribution in kind described in footnote (6). F13 · ownership.nature: Shares are held by IVP Executive Fund XVI, LLC ("IVP XVI EF"). IVM XVI is the manager of IVP XVI EF. The Managing Directors are the managing directors of IVM XVI and may be deemed to share voting and dispositive power over the shares held by IVP XVI EF. IVM XVI and each of the Managing Directors disclaims beneficial ownership of the shares held by IVP XVI EF except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:43 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 537,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016320 · doc4.xml · nonDerivative · entry 5 Institutional Venture Management XV, LLC · CIK 0001640275 · 10% owner Institutional Venture Management XVI, LLC · CIK 0001716997 · 10% owner Institutional Venture Partners XV, L.P. · CIK 0001640274 · 10% owner Institutional Venture Partners XV Executive Fund, L.P. · CIK 0001661321 · 10% owner Institutional Venture Partners XVI, L.P. · CIK 0001716992 · 10% owner IVP Executive Fund XVI, LLC · CIK 0001716965 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F11 · kind: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by IVM XV to its members without additional consideration. F10 · ownership.direct: Shares are held by IVM XV. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVM XV. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XV except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:43 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 537,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016320 · doc4.xml · nonDerivative · entry 4 Institutional Venture Management XV, LLC · CIK 0001640275 · 10% owner Institutional Venture Management XVI, LLC · CIK 0001716997 · 10% owner Institutional Venture Partners XV, L.P. · CIK 0001640274 · 10% owner Institutional Venture Partners XV Executive Fund, L.P. · CIK 0001661321 · 10% owner Institutional Venture Partners XVI, L.P. · CIK 0001716992 · 10% owner IVP Executive Fund XVI, LLC · CIK 0001716965 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,143 F9 · kind: Represents receipt of shares in the distribution in kind described in footnote (1). F2 · balance_after: The shares held by Institutional Venture Management XV, LLC ("IVM XV") prior to the transactions reported herein reflect the transfer of shares from IVM XV to IVP XV, which shares were previously held by IVM XV for the benefit of IVP XV and such transfer did not constitute a change in beneficial ownership. F10 · ownership.direct: Shares are held by IVM XV. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVM XV. Each of the Managing Directors disclaims beneficial ownership of the shares held by IVM XV except to the extent of his or its respective pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:43 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 2,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016320 · doc4.xml · nonDerivative · entry 3 Institutional Venture Management XV, LLC · CIK 0001640275 · 10% owner Institutional Venture Management XVI, LLC · CIK 0001716997 · 10% owner Institutional Venture Partners XV, L.P. · CIK 0001640274 · 10% owner Institutional Venture Partners XV Executive Fund, L.P. · CIK 0001661321 · 10% owner Institutional Venture Partners XVI, L.P. · CIK 0001716992 · 10% owner IVP Executive Fund XVI, LLC · CIK 0001716965 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Institutional Venture Partners XVI, L.P. Disclosed balance after: 7,709,091 F6 · kind: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XVI, L.P. ("IVP XVI") to its general partner and limited partners without additional consideration. F7 · balance_after: The shares held by Institutional Venture Management XVI, LLC ("IVM XVI") prior to the transactions reported herein reflect the transfer of shares from IVM XVI to IVP XVI, which shares were previously held by IVM XVI for the benefit of IVP XVI and such transfer did not constitute a change in beneficial ownership. F8 · ownership.nature: Shares are held by IVP XVI. IVM XVI is the sole general partner of IVP XVI. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XVI. Each of IVM XVI and the Managing Directors disclaims beneficial ownership of these securities, except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:43 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 13,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016320 · doc4.xml · nonDerivative · entry 2 Institutional Venture Management XV, LLC · CIK 0001640275 · 10% owner Institutional Venture Management XVI, LLC · CIK 0001716997 · 10% owner Institutional Venture Partners XV, L.P. · CIK 0001640274 · 10% owner Institutional Venture Partners XV Executive Fund, L.P. · CIK 0001661321 · 10% owner Institutional Venture Partners XVI, L.P. · CIK 0001716992 · 10% owner IVP Executive Fund XVI, LLC · CIK 0001716965 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Institutional Venture Partners XV Executive Fund, L.P. Disclosed balance after: 40,786 F4 · kind: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV EF") to its limited partners without additional consideration. F5 · ownership.nature: Shares are held by IVP XV EF. IVM XV is the sole general partner of IVP XV EF. The Managing Directors are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV EF. Each of IVM XV and the Managing Directors disclaims beneficial ownership of these securities, except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:43 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | OtherClass A Common Stock | 2,486,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016320 · doc4.xml · nonDerivative · entry 1 Institutional Venture Management XV, LLC · CIK 0001640275 · 10% owner Institutional Venture Management XVI, LLC · CIK 0001716997 · 10% owner Institutional Venture Partners XV, L.P. · CIK 0001640274 · 10% owner Institutional Venture Partners XV Executive Fund, L.P. · CIK 0001661321 · 10% owner Institutional Venture Partners XVI, L.P. · CIK 0001716992 · 10% owner IVP Executive Fund XVI, LLC · CIK 0001716965 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Institutional Venture Partners XV, L.P. Disclosed balance after: 7,668,334 F1 · kind: Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, by Institutional Venture Partners XV, L.P. ("IVP XV") to its general partner and limited partners without additional consideration. F2 · balance_after: The shares held by Institutional Venture Management XV, LLC ("IVM XV") prior to the transactions reported herein reflect the transfer of shares from IVM XV to IVP XV, which shares were previously held by IVM XV for the benefit of IVP XV and such transfer did not constitute a change in beneficial ownership. F3 · ownership.nature: Shares are held by IVP XV. IVM XV is the sole general partner of IVP XV. Todd C. Chaffee, Somesh Dash, Norman A. Fogelsong, Stephen J. Harrick, Eric Liaw, J. Sanford Miller, Dennis B. Phelps and Jules A. Maltz (collectively, the "Managing Directors") are the managing directors of IVM XV and may be deemed to share voting and dispositive power over the shares held by IVP XV. Each of IVM XV and the Managing Directors disclaims beneficial ownership of the shares held by IVP XV except to the extent of its or his respective proportionate pecuniary interest therein. Mr. Maltz is a director of the Issuer and files separate Section 16 reports. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.